TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bristol-Myers Squibb Norway AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
133,185
|
111,253
|
378,063 |
Financial expenses |
247
|
350
|
960 |
Earnings before taxes |
6,557
|
5,635
|
17,660 |
Total assets |
177,728
|
177,813
|
209,682 |
Current assets |
177,500
|
177,708
|
209,537 |
Current liabilities |
39,374
|
36,527
|
65,685 |
Equity capital |
138,354
|
141,286
|
143,997 |
- share capital |
663
|
565
|
596 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.8%
|
79.5%
|
68.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.9%
|
5.1%
|
4.7% |
Return on assets (ROA) |
3.8%
|
3.4%
|
8.9% |
Current ratio |
450.8%
|
486.5%
|
319.0% |
Return on equity (ROE) |
4.7%
|
4.0%
|
12.3% |
Change turnover |
28,768
|
-246,952
|
17,833 |
Change turnover % |
28%
|
-69%
|
5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.